Background: Narcolepsy results from immune-mediated destruction of hypocretin secreting neurons in hypothalamus, however the triggers and disease mechanisms are poorly understood. Vaccine-attributable risk of narcolepsy reported so far with the AS03 adjuvanted H1N1 vaccination Pandemrix has been manifold compared to the AS03 adjuvanted Arepanrix, which contained differently produced H1N1 viral antigen preparation. Hence, antigenic differences and antibody response to these vaccines were investigated. Methods and Findings: Increased circulating IgG-antibody levels to Pandemrix H1N1 antigen were found in 47 children with Pandemrix-associated narcoleps
PURPOSE OF REVIEW: A number of European countries have reported a dramatic increase in the rates of ...
The onset of narcolepsy, an irreversible sleep disorder, has been associated with 2009 influenza pan...
Narcolepsy is a rare neurological disorder characterized by excessive daytime sleepiness (EDS) with ...
Type 1 narcolepsy is caused by deficiency of hypothalamic orexin/hypocretin. An autoim-mune basis is...
After the mass-vaccination campaign during the influenza A (H1N1) 2009 pandemic, a significant incre...
Increased narcolepsy incidence was observed in Sweden following the 2009 influenza vaccination with ...
Epidemiological studies have demonstrated an association between H1N1 influenza infection and vaccin...
Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is stron...
After the connection between AS03-adjuvanted pandemic H1N1 vaccine Pandemrix and narcolepsy was reco...
AbstractThe vaccine safety surveillance system effectively detected a very rare adverse event, narco...
Evaluating new rare serious vaccine safety signals is difficult and complex work. To further assess ...
An increased incidence of narcolepsy type 1 (NT1) was observed in Scandinavia following the 2009–201...
The sleep disorder narcolepsy is linked to the HLA-DQB1*0602 haplotype and dysregulation of the hypo...
BACKGROUND: Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataple...
A group of scientific and public health experts and key stakeholders convened to discuss the state o...
PURPOSE OF REVIEW: A number of European countries have reported a dramatic increase in the rates of ...
The onset of narcolepsy, an irreversible sleep disorder, has been associated with 2009 influenza pan...
Narcolepsy is a rare neurological disorder characterized by excessive daytime sleepiness (EDS) with ...
Type 1 narcolepsy is caused by deficiency of hypothalamic orexin/hypocretin. An autoim-mune basis is...
After the mass-vaccination campaign during the influenza A (H1N1) 2009 pandemic, a significant incre...
Increased narcolepsy incidence was observed in Sweden following the 2009 influenza vaccination with ...
Epidemiological studies have demonstrated an association between H1N1 influenza infection and vaccin...
Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is stron...
After the connection between AS03-adjuvanted pandemic H1N1 vaccine Pandemrix and narcolepsy was reco...
AbstractThe vaccine safety surveillance system effectively detected a very rare adverse event, narco...
Evaluating new rare serious vaccine safety signals is difficult and complex work. To further assess ...
An increased incidence of narcolepsy type 1 (NT1) was observed in Scandinavia following the 2009–201...
The sleep disorder narcolepsy is linked to the HLA-DQB1*0602 haplotype and dysregulation of the hypo...
BACKGROUND: Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataple...
A group of scientific and public health experts and key stakeholders convened to discuss the state o...
PURPOSE OF REVIEW: A number of European countries have reported a dramatic increase in the rates of ...
The onset of narcolepsy, an irreversible sleep disorder, has been associated with 2009 influenza pan...
Narcolepsy is a rare neurological disorder characterized by excessive daytime sleepiness (EDS) with ...